 |
 Video: What is a Stock Split?
|
|
|
| TransMedics Group is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across various disease states. Co. has developed the Organ Care System (OCS), a portable organ perfusion and monitoring system that using Co.'s technology to replicate near-physiologic conditions for donor organs outside of the human body. The OCS was designed to perfuse donor organs with warm, oxygenated and nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. Co.'s OCS products are one for each of lung, heart and liver transplantations. According to our TransMedics Group stock split history records, TransMedics Group has had 0 splits. | |
|
TransMedics Group (TMDX) has 0 splits in our TransMedics Group stock split history database.
Looking at the TransMedics Group stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TransMedics Group shares, starting with a $10,000 purchase of TMDX, presented on a split-history-adjusted basis factoring in the complete TransMedics Group stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/03/2019 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$24.80 |
|
| End price/share: |
$127.99 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
416.09% |
|
| Average Annual Total Return: |
38.80% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$51,609.25 |
|
| Years: |
5.01 |
|
|
|
|
|
